Haemonetics HAE
NYSE HAE
$101.14 -2.02 (-1.96%)
As of: Sep 10, 2026 · 3:59 PM EDT

Haemonetics (HAE) Revenue Growth (1y) (2010 - 2026)

Analysis

Haemonetics (HAE) Revenue Growth (1y) (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (1y) (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn 13.02%
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn 18.54%
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn 13.73%
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn 9.42%
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn 7.53%
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn 13.63%
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn 7.95%
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn 13.08%
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn 7.30%
10 Haemonetics 4.60 Bn 4.37 Bn 202.80 Mn 5.60%
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 5.60%
Mar 28, 2026 4.76%
Dec 27, 2025 -2.75%
Sep 27, 2025 -5.27%
Jun 28, 2025 -4.40%
Mar 29, 2025 -3.70%
Dec 28, 2024 3.66%
Sep 28, 2024 8.59%
Jun 29, 2024 7.98%
Mar 30, 2024 12.77%
Dec 30, 2023 10.14%
Sep 30, 2023 6.96%
Jul 1, 2023 19.08%
Apr 1, 2023 14.87%
Dec 31, 2022 17.53%
Oct 1, 2022 24.01%
Jul 2, 2022 14.41%
Apr 2, 2022 17.76%
Jan 1, 2022 8.07%
Oct 2, 2021 14.52%